Athersys to Present at 17th Annual BIO CEO & Investor Conference
February 03 2015 - 3:00PM
Athersys, Inc. (Nasdaq:ATHX) announced today that it will present
at the 17th annual BIO CEO & Investor Conference to be held on
February 9-10, 2015 in New York, NY, at The Waldorf Astoria New
York.
Gil Van Bokkelen, Chairman and Chief Executive Officer, will
present on Tuesday, February 10, 2015 at 11:00 a.m. EST in the Park
North Room.
The BIO CEO & Investor Conference is one of the largest
investor conferences focused on established and emerging
publicly-traded and select private biotech companies. Because its
mission is to support industry-wide success, BIO presents a broad
and unbiased view of investment opportunities and provides an
annual forum for institutional investors, industry analysts, and
senior biotechnology executives to shape the future investment
landscape of the industry.
To listen to the live audio webcast of the presentation during
the event, please visit: www.athersys.com. A replay of the webcast
will be available for 90 days after the initial presentation.
About Athersys
Athersys is an international biotechnology company engaged in
the discovery and development of therapeutic product candidates
designed to extend and enhance the quality of human life. The
Company is developing its MultiStem® cell therapy product, a
patented, adult-derived "off-the-shelf" stem cell product,
initially for disease indications in the cardiovascular,
neurological, inflammatory and immune disease areas, and has
several ongoing clinical trials evaluating this potential
regenerative medicine product. Athersys has forged strategic
partnerships and collaborations with leading pharmaceutical and
biotechnology companies, as well as world-renowned research
institutions to further develop its platform and products. More
information is available at www.athersys.com.
CONTACT: William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
bjlehmann@athersys.com
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Sep 2023 to Sep 2024